Health services and systems: latest news

Health services and systems resources

Health services and systems features

Health services and systems in your own words

  • Going into hospital

    My experiences of hospitalisation are mixed. I’ve been admitted twice in the last six months, both times for a minor operation. However, following the excellent...

    From: In your own words

Health services and systems news from aidsmap

More news

Health services and systems news selected from other sources

  • Complaint Says Insurance Plans Discriminate Against HIV Patients

    Four Florida insurers allegedly discriminate against people with HIV/AIDS by structuring their prescription drug benefits so that patients are discouraged from enrolling, according to a complaint filed by health advocacy groups.

    09 July 2014 | NPR
  • HIV interventions will not reach those who need them without increased efficiencies, review says

    While noting that HIV service delivery can’t be increased to needed levels with reduced resources, authors of a systematic review published in the July World Health Organization Bulletin say more efficient use of existing resources will be critical to making meaningful reductions in prevalence and infection rates.

    04 July 2014 | Science Speaks
  • Between credibility and conflict of interest

    "AIDS organizations don’t represent us”; “Others are making their names with their HIV/AIDS work without producing tangible benefits for people with HIV.” I’m paraphrasing, of course, but the sentiments and the expression of them should be familiar to anyone living with HIV or working in the HIV field.

    04 July 2014 | Positive Lite
  • Why HIV Drug Costs Are Spiking Under Obamacare

    Since the start of this year, many people with HIV have seen the out-of-pocket costs of their medications skyrocket. And advocates argue it's not just price-gouging, but a blatant attempt to discriminate against patients who need expensive treatments.

    01 July 2014 | BuzzFeed
  • Dolutegravir in HIV-1 infection: Added benefit in adult patients

    The German Institute for Quality and Efficiency in Health Care (IQWiG) has determined that the new integrase inhibitor drug dolutegravir (Tivicay ®) is of considerable added benefit to treatment-naive patients in comparison with current first-line therapies, and some added benefit to patients who already need to take an integrase inhibitor.

    19 June 2014 | Science Daily
  • Older HIV patients 'need more support'

    The older generation of people with HIV need better support to keep them well, nurses say. About a quarter of the 100,000 people with HIV in the UK are aged over 50.

    16 June 2014 | BBC Health
  • Michael Saag: What US health care reform could learn from HIV history

    Our health care system is sick, says Alabama AIDS physician Michael Saag, MD, in his memoir, Positive: One Doctor’s Personal Encounters With Death, Life and the U.S. Healthcare System. But the prognosis isn’t fatal. Here, he explains what health care reform could learn from HIV history.

    10 June 2014 | Poz
  • Marriage a Barrier to ARV treatment for Swazi Women (part two of a series on Option B+)

    This is the second in a three-part series of about women and Option B+ in Africa. "Although Swazi women have better health-seeking behaviour than men, they find it hard to deal with HIV because of socio-cultural barriers, says the study. Many HIV positive married women live in a dilemma between obeying their husbands or following the advice of the health workers."

    05 June 2014 | IPS
  • Bias Claims for Insurers in Coverage of HIV

    Health care advocates said on Thursday that four insurers offering plans in the new federal marketplace discriminated against people with HIV or AIDS by requiring them to pay high out-of-pocket costs for drugs to treat HIV, including generic medications.

    30 May 2014 | New York Times
  • TB drug approvals, distribution deal inches options forward, but MDR TB treatment access still uncertain where needed most

    Last week’s important developments in TB treatment included the announcement that bedaquiline, the currently most promising medicine for multi-drug-resistant tuberculosis, will become available to patients in 130 low- and middle-income countries through the Stop TB Partnership’s Global Drug Facility.

    14 May 2014 | Science Speaks
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.